Head to head
Mesa Laboratories vs Coherent
Side-by-side on the measures that matter, with a plain-English read. Full detail: MLAB · COHR
MLAB
Mesa Laboratories
129.96-4.48%
1-year price shape — +92% over the period
Quant Rating C · 66/100
vs
COHR
Coherent
334.56-1.12%
1-year price shape — +195% over the period
Quant Rating B · 98/100
1-year performance, rebased to 100
Coherent edges it on the scoreable measures. Coherent has the highest Quant Rating (98); Coherent has done best over the past year (+195%); Coherent trades cheapest on trailing earnings.
| MLAB | COHR | |
|---|---|---|
| Snapshot | ||
| Sector | Scientific & Technical Instruments | -- |
| Last price | 129.96 | 334.56 |
| Change today | -4.48% | -1.12% |
| 1-year return | +91.8% | +194.6% |
| Market cap | $727.24M | $65.52B |
| 52-week range | 66.13 – 144.35 | 108.19 – 440.00 |
| Valuation | ||
| P/E (TTM) | 152.89 | 81.20 |
| P/E percentile, own 5-yr range | 67th | 80th |
| P/B | 3.85 | 6.01 |
| Dividend yield | 0.49% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | 1.21 | 4.12 |
| Net profit (TTM) | $6.77M | $806.83M |
| Revenue (TTM) | $249.73M | $7.12B |
| Revenue growth (YoY) | +1.0% | +33.7% |
| Gross margin | 64.2% | 37.5% |
| Operating margin | 9.0% | 12.7% |
| Net margin | 1.9% | 10.8% |
| Free cash flow (TTM) | $52.87M | $-1.03B |
| Ownership & sentiment | ||
| Institutional ownership | 90.7% | 88.0% |
| Insider activity (12mo) | 27 buy / 13 sell | 19 buy / 29 sell |
| Short interest (% of float) | 7.2% | 5.2% |
| Analyst consensus | -- | 79% buy / 21% hold (14) |
| Analyst price target | -- | $427 (+28%) |
| StockVane view | ||
| StockVane Quant Rating | C (66) | B (98) |
| Company | ||
| Employees | 717 | 5,085 |
| Founded | 1982 | 1971 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.